The startup “Sono Motors”, missed its crowdfunding target of $56 million (€50 million). The campaign fell about $22 million (€20 million) short of its goal. Just before the campaign closed the startup posted “The Sion is in danger. Four more days. Only a Christmas miracle can save it,” on LinkedIn.
Get comprehensive access to global business, stock market and finance headlines, and trending topics like bitcoin and crowdfunding. Born2Invest brings you the latest news from around the world and across the spectrum of the trusted global network.
Missed the target, still hit a crowdfunding record
Nevertheless, within 30 days – orchestrated by a massive PR campaign – the Munich startup collected almost $33 million (€30 million) from supporters of the electric car project, thus completing one of the largest crowdfunding campaigns of any European startup.
As listed on the startup’s website, 3,400 existing reservations increased their pledges, amounting to $22,07 million (€19,7 million). The startup also booked new reservations with a total value of $8,29 million (€7,4 million). Supporters also granted loans of $1,12 million (€1 million) and donated $96,393 (€86,000). However, presumably because of the uncertain future of the project, there were also 720 cancellation requests worth $1,56 million (€1.4 million).
Sono Motors wants to build an electric car with solar cells
The new capital was to be invested primarily in production facilities and series prototypes of the first Solar Electric Vehicle Sion. The startup has been announcing the launch of this vehicle for some time now.
Sion is planned to be the first “series-production” vehicle to combine solar integration, mobility services, and a bidirectional charging function (i.e. the car should not only be able to charge but also to deliver electricity) in one vehicle. By integrating solar cells into the vehicle surface, the city car should become independent of the charging infrastructure over short distances.
According to the startup, this means that up to 5,800 kilometers of free and climate-neutral coverage can be achieved annually, thus reducing operating costs accordingly. Sono Motors plans to produce up to 260,000 vehicles with renewable energy in the disused Saab brand plant in Sweden.
Tests for the Sion have been running since 2016
Sono Motors was founded in 2016 by Navina Pernsteiner, Jona Christians, and Laurin Hahn. The beginnings of the idea date back to six years ago. The founders had already financed the test model through a crowdfunding campaign, giving the Founders the opportunity to test a vehicle on a research campus as early as 2018.
In March 2019, the start-up had finally shown another prototype. This time with a “final design,” but at a higher price of $5,604 (€5000). Originally, the electric car was to cost $22 million (€20 million). The year 2019 was then named as the market launch.
As a result of the realignment of the start-up company and the decision to forego borrowing for development and prototyping, the production of the first vehicles was then postponed until September 2021, which the company announced in December 2019 and once again, more than 10,000 supporters waiting for the Sion were told to wait.
Photovoltaics and moss: Ambitious plans of the Munich start-up
The founders of Sono Motors had several ideas and plans, first being to build an electric car (Tesla showed how difficult that is), the second to achieve this through crowdfunding. The start-up also wanted to offer the car together with a sharing concept, with the fourth and final idea being to provide extras such as providing a built-in moss ventilation system or photovoltaic cells as an additional energy supply.
On Monday, December 30th, Sono spokesperson, Alexa Rauscher said: “It is not too late!”. He stated that “We will not throw in the towel immediately.”, but first, the community should be informed. After that, the startup will comment on further plans.
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Gruenderszene, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Your 2020 guide on how to get the most out of video marketing
Video content marketing has increased in popularity. From ways to incorporate engaging footage into your campaigns, to the latest social...
The biggest estate planning blunders of all time
About 55% of Americans do not have a will. Even more worrisome is the fact that less than 1 in...
These marijuana stocks are gaining traction among Gen Z
Members of generation Z are utilizing their not-inconsiderable buying power in unique ways that are different than any generation before...
Could ElsaLys Biotech have a breakthrough treatment for Graft-verses-host disease?
ElsaLys Biotech is an immuno-oncology company that designs a new generation of therapeutic antibodies that target tumors and their immune...
Senegal’s Banks look to target the African disporia in the West
Remittances from relatives or friends living abroad represent an essential lifeline for many families in Sub-Sarah Africa. For example Senegalese...
- Crypto6 days ago
How blockchain technology is disrupting gambling
- Featured7 days ago
“As the World Turns” – a forecast for what might happen in the world economy this week
- Crowdfunding5 days ago
How crowdfunding helped this gaming company succeed
- Biotech7 days ago
The four young Spanish researchers selected by MIT